Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2551 AL 2565

Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases

Iyer S, Bhat I, Bangera Sheshappa M.

Mol Nutr Food Res. 2024 Jul;68(13):e2300409. doi: 10.1002/mnfr.202300409. Epub 2024 Mar 15.

Biomarkers for Managing Neurodegenerative Diseases

Cheslow L, Snook AE, Waldman SA.

Biomolecules. 2024 Mar 26;14(4):398. doi: 10.3390/biom14040398.

Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders

Yadav S, Deepika, Moar K, Kumar A, Khola N, Pant A, Kakde GS, Maurya PK.

Biol Cell. 2024 Jul;116(7):e2400019. doi: 10.1111/boc.202400019. Epub 2024 May 31.

Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine

Wang Q, Gu X, Yang L, Jiang Y, Zhang J, He J.

Front Aging Neurosci. 2024 Jul 4;16:1417515. doi: 10.3389/fnagi.2024.1417515. eCollection 2024.

Clinical characteristics and treatment of psychosis in Parkinson's disease: A narrative review

Stamenović J, Živadinović B, Đurić V.

J Chin Med Assoc. 2024 Nov 1;87(11):972-979. doi: 10.1097/JCMA.0000000000001146. Epub 2024 Aug 9.

Transition Metal Complexes as Therapeutics: A New Frontier in Combatting Neurodegenerative Disorders through Protein Aggregation Modulation

Navale GR, Ahmed I, Lim MH, Ghosh K.

Adv Healthc Mater. 2024 Dec;13(31):e2401991. doi: 10.1002/adhm.202401991. Epub 2024 Sep 2.

MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets

Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O.

NPJ Parkinsons Dis. 2024 Oct 5;10(1):186. doi: 10.1038/s41531-024-00791-2.

Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease

Li Y, Zhang J, Ma B, Yu W, Xu M, Luan W, Yu Q, Zhang L, Rong R, Fu Y, Cao H.

Int J Pharm. 2024 Dec 5;666:124786. doi: 10.1016/j.ijpharm.2024.124786. Epub 2024 Oct 6.

Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration

Trisal A, Singh AK.

Cell Mol Neurobiol. 2024 Oct 16;44(1):67. doi: 10.1007/s10571-024-01493-2.

Vagus nerve stimulation in Parkinson's disease: a scoping review of animal studies and human subjects research

Evancho A, Do M, Fortenberry D, Billings R, Sartayev A, Tyler WJ.

NPJ Parkinsons Dis. 2024 Oct 24;10(1):199. doi: 10.1038/s41531-024-00803-1.

Refining the clinical diagnosis of Parkinson's disease

Mulroy E, Erro R, Bhatia KP, Hallett M.

Parkinsonism Relat Disord. 2024 May;122:106041. doi: 10.1016/j.parkreldis.2024.106041. Epub 2024 Feb 10.

Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts

Moors TE, Milovanovic D.

J Parkinsons Dis. 2024;14(1):17-33. doi: 10.3233/JPD-230183.

[Synergies Instead of Rivalries - Expert Opinion on the Misunderstood Roles of Continuous Intrajejunal Levodopa Therapy and Deep Brain Stimulation in the Treatment of Parkinson̓s Disease]

Schröter N, Jost WH, Rijntjes M, Coenen V, Groppa S, Sajonz B.

Fortschr Neurol Psychiatr. 2024 Dec;92(12):502-508. doi: 10.1055/a-2238-1641. Epub 2024 Feb 12.

Gut microbiota in neurological diseases: Melatonin plays an important regulatory role

Ahmadi S, Taghizadieh M, Mehdizadehfar E, Hasani A, Khalili Fard J, Feizi H, Hamishehkar H, Ansarin M, Yekani M, Memar MY.

Biomed Pharmacother. 2024 May;174:116487. doi: 10.1016/j.biopha.2024.116487. Epub 2024 Mar 21.

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

Adamu A, Li S, Gao F, Xue G.

Front Aging Neurosci. 2024 Apr 12;16:1347987. doi: 10.3389/fnagi.2024.1347987. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias